Chet R. Villa, MD
- Pediatric Cardiologist, Heart Failure & Transplantation
- Professor, UC Department of Pediatrics
- chet.villa@cchmc.org
- Board Certified
About
Biography
Children with severe heart disease once had few clinical options. While we’ve made many advances, it’s still critical that we improve therapeutic options and develop new approaches.
At Cincinnati Children’s, I care for children with complex medical needs and severe heart disease. This includes children with Duchenne muscular dystrophy, RASopathies, and those in need of ventricular assist device therapy and heart transplant.
My research is focused on finding ways to provide care to children and young adults with heart disease who have limited access to advanced therapies.
MD: University of Cincinnati College of Medicine, Cincinnati, OH, 2007
Residency: Pediatrics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
Certifications: American Board of Pediatrics, 2010; Pediatric Cardiology, 2014
Interests
Advanced heart failure; heart transplantation; cardiomyopathy; mechanical circulatory support
Interests
Ventricular assist device therapy; Duchenne muscular dystrophy
Insurance Information
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Publications
Prospective Multicenter Evaluation of a Novel Active Driving System for Pediatric Ventricular Assist Device Support. Journal of the American College of Cardiology. 2026; 87(22):3171-3182.
Cardiac MRI in cardiac dystrophinopathy: recommendations on imaging. Open Heart. 2026; 13(1).
Fatal Fat Embolism Syndrome Without Recognized Fracture in Patients With Duchenne Muscular Dystrophy: Two Case Reports. Pediatric Neurology. 2026; 181:51-55.
From case to caution: hyponatremia in a patient with Duchenne muscular dystrophy on vamorolone and lessons for clinicians. Neuromuscular Disorders. 2026; 62:106411.
Cardiac Medication Use in ACTION for Duchenne Muscular Dystrophy Cardiomyopathy. Pediatric Cardiology. 2026; 47(4):1439-1450.
(1491) Beyond the Heart: Challenges of Heart Transplant in Alstrom Syndrome. The Journal of Heart and Lung Transplantation. 2026; 45(5):686.
A homozygous variant in cardiac troponin I3, TNNI3, causes severe pediatric restrictive cardiomyopathy. HGG Advances. 2026; 7(3):100598.
1571 Autopsy Evaluation of the Patterns of Liver Pathology in Duchenne Muscular Dystrophy. Laboratory Investigation. 2026; 106(3):105871.
Dystrophinopathy in ACTION: The first 500 males enrolled in the Advanced Cardiac Therapies Improving Outcomes Network prospective dystrophinopathy registry. Neuromuscular Disorders. 2026; 58:106278.
Heart Transplantation and Ventricular Assist Device in Duchenne Muscular Dystrophy: A New Era. Pediatric Transplantation. 2026; 30(1):e70253.
From the Blog
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 2026 Cincinnati Children's Hospital Medical Center. All rights reserved.
Patient Ratings and Comments
All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent experience management company, Qualtrics. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey